Tumor-cell-specific CD8+ T lymphocytes exhibited a more potent cytotoxic effect on TNBC cells in vitro compared to CIK cells activated by cytokines, highlighting the specificity of these T cells in targeting and eliminating TNBC cells (Fig. 2C). This evidence concerns the gene CD8A and neoplasm.